HIV-1 protease inhibitor drug resistance in Kenyan antiretroviral treatment-naive and -experienced injection drug users and non-drug users

BACKGROUND: Although injection drug use drives antiretroviral drug resistance, the prevalence of protease inhibitor (PI) resistance among Kenyan IDUs remains undetermined. We, therefore, explored PI resistance mutations and their association with viral load and CD4+ T cell counts in HIV-1 infected I...

Descripción completa

Detalles Bibliográficos
Autores principales: Budambula, Valentine, Musumba, Francis O., Webale, Mark K., Kahiga, Titus M., Ongecha-Owuor, Francisca, Kiarie, James N., Sowayi, George A., Ahmed, Aabid A., Ouma, Collins, Were, Tom
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537595/
https://www.ncbi.nlm.nih.gov/pubmed/26279669
http://dx.doi.org/10.1186/s12981-015-0070-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537595/
https://www.ncbi.nlm.nih.gov/pubmed/26279669
http://dx.doi.org/10.1186/s12981-015-0070-y

Ejemplares similares